Clinical Genomics
Max Mawhinney was a co-founder and largest shareholder of Enterix Inc. in 1997 and is a co-founder and largest shareholder in Clinical Genomics Technologies. In addition to his experience in managing technology start-ups, Max was previously the founder and Managing Director of ICA Property, a company specialising in major industrial and commercial projects. ICA Property initiated a number of substantial development funds raising capital from major Australian institutional investors. Through ICA Property, Max was responsible for over $1billion in projects and has extensive experience in all aspects of business management and he has served on the Board of a number of Australian companies. Max was also a founding Director of the Property Industry Foundation, a charity set up to raise money to provide facilities for “kids on the streets” in Sydney. He was also a founding Director of the Urban Task Force, the major property industry lobby group. Max also has extensive farming interests.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Clinical Genomics
1 followers
Clinical Genomics is a privately held biotechnology company developing products for colorectal cancer diagnosis and recurrence monitoring.